European drug traffickers are leveraging AI-boosted chemical synthesis to create designer drug precursors that circumvent existing product blacklists, according to an EU agency warning.
The European Union has flagged a growing threat from criminal organizations using artificial intelligence to develop novel chemical compounds that fall outside regulatory controls. Gang operators are tapping AI capabilities for chemical synthesis to manufacture precursors—intermediate substances used in illegal drug production—that differ from currently banned formulas.
The shift represents a significant enforcement challenge. Traditional drug control relies on blacklisting known chemical precursors, but AI-generated variants can effectively bypass these restrictions while maintaining psychoactive properties.
EU officials warned that traffickers are increasingly adopting advanced technologies to develop and distribute illicit substances. The acceleration of AI adoption in chemistry has expanded capabilities beyond legitimate pharmaceutical and research applications, creating new regulatory gaps.
The development underscores mounting concerns about dual-use AI technologies—tools designed for legitimate purposes but applicable to harmful activities. European authorities are now examining how to adapt drug control frameworks to address AI-generated compounds and precursor variations.
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) alerted federal agencies that ransomware gangs are actively exploiting a critical JetBrains TeamCity vulnerability that was patched in July.
A Senate Judiciary Subcommittee criticized automatic license plate reader technology Wednesday, with particular concerns raised about Flock Safety. The company's CEO and others declined to attend the hearing.
The domain third-party.com, widely used in developer documentation as a placeholder, is now hosting a fake Cloudflare verification page designed to trick Windows users into executing malicious PowerShell commands.